My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Sep 14,2016

Net profit of Jindal Drilling & Industries declined 3.66% to Rs 9.48 crore in the quarter ended June 2016 as against Rs 9.84 crore during the previous quarter ended June 2015. Sales rose 11.24% to Rs 92.66 crore in the quarter ended June 2016 as against Rs 83.30 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales92.6683.3011
OPM %9.8912.74-
PBDT14.5518.68-22
PBT12.0915.01-19
NP9.489.84-4

Powered by Capital Market - Live News

Surya Industrial Corporation to hold board meeting
May 30,2017

Surya Industrial Corporation will hold a meeting of the Board of Directors of the Company on 30 May 2017.

Powered by Capital Market - Live News

Bilpower to hold board meeting
May 30,2017

Bilpower will hold a meeting of the Board of Directors of the Company on 30 May 2017.

Powered by Capital Market - Live News

Healthy Investments to hold board meeting
May 30,2017

Healthy Investments will hold a meeting of the Board of Directors of the Company on 30 May 2017.

Powered by Capital Market - Live News

Asya Infosoft to hold board meeting
May 30,2017

Asya Infosoft will hold a meeting of the Board of Directors of the Company on 30 May 2017.

Powered by Capital Market - Live News

Farry Industries to hold board meeting
May 30,2017

Farry Industries will hold a meeting of the Board of Directors of the Company on 30 May 2017.

Powered by Capital Market - Live News

Inani Securities to hold board meeting
May 30,2017

Inani Securities will hold a meeting of the Board of Directors of the Company on 31 May 2017.

Powered by Capital Market - Live News

BMB Music & Magnetics to hold board meeting
May 30,2017

BMB Music & Magnetics will hold a meeting of the Board of Directors of the Company on 30 May 2017.

Powered by Capital Market - Live News

REIL Electricals India to hold board meeting
May 30,2017

REIL Electricals India will hold a meeting of the Board of Directors of the Company on 30 May 2017.

Powered by Capital Market - Live News

SGN Telecoms to hold board meeting
May 30,2017

SGN Telecoms will hold a meeting of the Board of Directors of the Company on 30 May 2017.

Powered by Capital Market - Live News

Board of Bharat Petroleum Corporation recommends bonus issue of 1:2
May 30,2017

Bharat Petroleum Corporation announced that the Board of Directors of the Company at its meeting held on 29 May 2017 has recommended for the approval of the shareholders, through Postal Ballot and e-voting, issue of fully paid bonus shares in the ratio of 1:2 i.e. 1 (one) new bonus equity share of Rs. 10 each for every existing 2 (two) equity shares of Rs. 10 each.

The Bonus shares after the approval of the Shareholders, would result in capitalization of a sum of Rs. 723.08 crore. Accordingly, the paid up equity share capital of the Company would stand revised to Rs. 2,169.25 crore from the present level of Rs. 1,446.17 crore.

The above bonus shares shall rank pari passu in all respects with the existing share except that these bonus shares shall not be eligible for final dividend for the year ended 31 March 2017.

Powered by Capital Market - Live News

8K Miles Software Services announces closing of acquisition of Cornerstone Advisors Group
May 30,2017

8K Miles Software Services announced the closing of Cornerstone Advisors Group, LLC acquisition, a national leader in health information technology advisory and implementation services. The acquisition brings the world class cloud hosting and technology solutions of 8K Miles to Cornerstones clients, allowing them to optimise their EHR efforts, manage data more effectively, improve patient care and reduce healthcare costs.

Powered by Capital Market - Live News

Aurobindo Pharma advances after Q4 results
May 30,2017

The result was announced after market hours yesterday, 29 May 2017.

The stock had fallen 3.67% to Rs 513.70 yesterday, 29 May 2017, ahead of its Q4 results.

Meanwhile, the S&P BSE Sensex was up 88.74 points, or 0.29%, to 31,197.66.

Higher than usual volumes were witnessed on the counter. On the BSE, 4.38 lakh shares were traded in the counter so far, compared with average daily volumes of 2.57 lakh shares in the past one quarter. The stock had hit a high of Rs 547.45 and a low of Rs 506 so far during the day.

The stock had hit a record high of Rs 895 on 6 October 2016. The stock had hit a 52-week low of Rs 504 yesterday. 29 May 2017. The stock had underperformed the market over the past one month till 29 May 2017, falling 15.24% compared with the 3.98% gains in the Sensex. The scrip had also underperformed the market in past one quarter, falling 24.14% as against Sensexs 8.23% gains.

The large-cap company has equity capital of Rs 58.59 crore. Face value per share is Re 1.

Aurobindo Pharmas consolidated net profit fell 3.9% to Rs 532.90 crore on 2.8% decline in operating income to Rs 3641.60 crore in Q4 March 2017 over Q4 March 2016.

The companys board of Directors approved second interim dividend of Rs 1.25 per share for the year ended 31 March 2017 (FY 2017).

EBITDA (earnings before interest, taxes, depreciation and amortization) before forex and other income fell 16.74% to Rs 721 crore in Q4 March 2017 over Q4 March 2016. EBITDA was impacted by one-time inventory write-off and other exceptional items. EBITDA margin fell to 19.8% in Q4 March 2017 from 23.1% in Q4 March 2016.

The board of directors decided not to transfer its injectable unit on a going concern basis comprising assets and liabilities pertaining to the unit to its wholly owned subsidiary namely, Curepro Parenterals, considering the expansion and growth plans of the company. The decision is subject to the approval of appropriate authorities including High Court or Tribunal as the case may be.

The board of directors on 12 September 2013 had approved the transfer of the unit. The same was subject to requisite consents, approvals or permissions of the statutory or regulatory authorities. Pending such approvals, no effect of this scheme was given till date.

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients.

Powered by Capital Market - Live News

Selan Explorations Technology to hold board meeting
May 30,2017

Selan Explorations Technology will hold a meeting of the Board of Directors of the Company on 3 June 2017, to consider the proposal for Buyback of Equity Shares

Powered by Capital Market - Live News

Flex Foods to pay dividend
May 30,2017

Flex Foods announced that dividend, if approved, will be paid after 12 August 2017.

Powered by Capital Market - Live News

Basant Agro Tech (India) to pay dividend
May 30,2017

Basant Agro Tech (India) announced that dividend, if approved, will be paid on or after 28 September 2017.

Powered by Capital Market - Live News